共 70 条
[1]
Jung A., Maier R., Vartanian J.P., Et al., Multiply infected spleen cells in HIV patients, Nature, 418, (2002)
[2]
Mansky L.M., Temin H.M., Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase, J Virol, 69, pp. 5087-5094, (1995)
[3]
Lal R.B., Chakrabarti S., Yang C., Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy and vaccine development, Indian J Med Res, 121, pp. 287-314, (2005)
[4]
Domingo E., Holland J.J., RNA virus mutations and fitness for survival, Annu Rev Microbiol, 51, pp. 151-178, (1997)
[5]
Domingo E., Verdaguer N., Ochoa W.F., Et al., Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus, Virus Res, 62, pp. 169-175, (1999)
[6]
Troyer R.M., Collins K.R., Abraha A., Et al., Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression, J Virol, 79, pp. 9006-9018, (2005)
[7]
Quinones-Mateu M.E., Ball S.C., Marozsan A.J., Et al., A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression, J Virol, 74, pp. 9222-9233, (2000)
[8]
Lukashov V.V., Goudsmit J., Founder virus population related to route of virus transmission: A determinant of intrahost human immunodeficiency virus type 1 evolution?, J Virol, 71, pp. 2023-2030, (1997)
[9]
Nowak M.A., Anderson R.M., McLean A.R., Et al., Antigenic diversity thresholds and the development of AIDS, Science, 254, pp. 963-969, (1991)
[10]
Nowak M.A., May R.M., Phillips R.E., Et al., Antigenic oscillations and shifting immunodominance in HIV-1 infections, Nature, 375, pp. 606-611, (1995)